- ►hematologylibrary.org JM Muche, A Lukowsky, K Asadullah, S … - Blood, 1997 - bloodjournal.hematologylibrary.org Clonal T cells have been demonstrated in skin lesions of all stages of cutaneous
T-cell lymphomas (CTCLs). However, there are conflicting data regarding the CTCL
stage at which dissemination of clonal cells into peripheral blood occurs. ... Cited by 127 - Related articles - BL Direct - All 5 versions
M Duvic, AG Martin, Y Kim, E Olsen, GS … - Archives of Dermatology, 2001 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 126 - Related articles - BL Direct - All 5 versions
EA Olsen, ST Rosen, RT Vollmer, D … - Journal of the American Academy of Dermatology, 1989 - Elsevier Twenty-two patients with Stages la to IVa cutaneous T cell lymphoma were entered
into a controlled trial of interferon alfa-2a (Roferon-A). Patients initially
received either 3 million IU interferon alfa-2a, or their dosage was ... Cited by 115 - Related articles - All 5 versions
- ►hematologylibrary.org [PDF] I Theodorou, MH Delfau-Larue, C Bigorgne, C … - Blood, 1995 - bloodjournal.hematologylibrary.org In cutaneous T-cell infiltrates, the demonstration of a clonal T-cell receptor
(TCR) gene rearrangement has been consid- ered helpful to distinguish Cutaneous
T-cell lymphomas from reactive lymphoproliferation. Hence, a polymerase ... Cited by 97 - Related articles - BL Direct - All 4 versions
PA Bunn Jr, DC Ihde, KA Foon - CA A Cancer Journal for Clinicians - interscience.wiley.com Maximally tolerated doses of interferon alfa-2a, 50 × 10 6 U/m 2 administered
intramuscularly (IM) 3 times weeklywere given to 20 patients with advanced
stages of cutaneous T-cell lymphoma (CTCL) to determine the efficacy and ... Cited by 95 - Related articles - All 2 versions
- ►jcojournal.org [PDF] RT Hoppe, EA Abel, DG Deneau, NM Price - Journal of Clinical Oncology, 1987 - jcojournal.org The technique of treatment, response rate, freedom from relapse, survival, and
complications of therapy in 123 patients treated with topical nitrogen mustard
(HN2) for cutaneous mycosis fungoides (MF) at Stan- ford University Medical ... Cited by 76 - Related articles - All 5 versions
P Heald, SL Yan, R Edelson - Archives of Dermatology, 1994 - archderm.highwire.org Page 1. Profound Deficiency in Normal Circulating T Cells in Erythrodermic Cutaneous
T-Cell Lymphoma Peter Heald, MD; Shu-Ling Yan, MD; Richard Edelson, MD ... Cited by 72 - Related articles - BL Direct - All 4 versions
E Ralfkiaer, NTJ O'Connor, J Crick, GL … - Journal of Investigative Dermatology, 1987 - nature.com The gene encoding the beta-chain of the T-cell antigen receptor (TCR) has been
analyzed for evidence of rearrangement in skin, blood, and lymph node specimens
from 23 cases of known or suspected cutaneous T-cell lymphoma (CTCL). Two ... Cited by 70 - Related articles - All 3 versions
D Catovsky, R Foa, 1990 - Informa Pharma Science There are undoubtedly reasons for writing a book about the lymphoid leukemias.
For example, the results of chemotherapy are better in acute lymphoid leukemia
than in any other acute leukemia and in no other type of leukemia are ... Cited by 67 - Related articles - All 2 versions
GS Wood, SR Hong, DT Sasaki, EA Abel, RT … - Journal of the American Academy of Dermatology, 1990 - Elsevier Deficiencies of Leu-8 and CD7 antigens are exhibited by CD3 + T cells in the
skin lesions of most patients with mycosis fungoides/Sézary syndrome. To
determine whether these antigenic abnormalities are limited to involved ... Cited by 65 - Related articles - All 4 versions
